The specialty pharma industry has historically been an area filled with dealmaking but has been more subdued over the past few years.
Not exact matches
That deal cemented Actavis's rebirth as a branded and
specialty pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&
pharma company — or as CEO Brent Saunders said, a pioneer «in a new
industry model: Growth
Pharma.&
Pharma.»
We cover biopharma companies end - to - end — whether they're small,
specialty drugmakers, generics companies or the biggest of Big
Pharma — highlighting the accomplishments and acknowledging the defeats that all of them experience in the complicated, competitive pharmaceuticals
industry.